Two of the vaccines we have for COVID-19 have the distinction of being the first mRNA vaccines to see widespread use in ...

Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer vaccine, when combined with the immunotherapy Keytruda (pembrolizumab), has been associated with a 49% ...

mRNA vaccines stopped the COVID-19 pandemic in its tracks. Now, they're poised to help us against the flu, rabies, cancer, and more. Hosted by: Niba @NotesbyNiba (she/her) ---------- Support us for $8 ...

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...

The only man in his immediate family to be without a cancer diagnosis, one Lynch syndrome patient made the trip to ...

A new study published in the Proceedings of the National Academy of Sciences suggests that rare cases of brain inflammation ...

A case in point is the dire need for new antimicrobials, but pharmaceutical companies have little financial incentive to ...

From smartphones to net zero, there has been no shortage of innovative ideas in the past 25 years, which is why we have taken ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine - which designs nanotechnology-based platforms for clinical translation across specialties - developed a ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...